glp 1 drugs alzheimer's Frontiers Alzheimer's: Ozempic and Similar Drugs

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder, primarily characterized by a decrease in insulin secretion and typically accompanied by insulin resistance

Ozempic was designed for diabetes

Results At 1 year, patients achieved significant weight loss with a median total weight loss (%TWL) of 25.5% and a median excess weight loss (%EWL) of 66.3% compared to 16.6% and 40.8%, respectively, at treatment initiation with BMI reduction of 3.7 kg/m2

this finding should be interpreted cautiously given the retrospective design, active and non-inert comparator, and likelihood of residual confounding

Incretin Agents

Learn differences, results, side effects, and which weight loss option is right for you.